• Intellia, Regeneron, Viatris + Oyster Point

  • Nov 16 2022
  • Duración: 10 m
  • Podcast

Intellia, Regeneron, Viatris + Oyster Point  Por  arte de portada

Intellia, Regeneron, Viatris + Oyster Point

  • Resumen

  • More CRISPR data, oncology wins, and a new player in ophthalmology

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Intellia
    Regeneron
    Viatris + Oyster Point

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    Más Menos

Lo que los oyentes dicen sobre Intellia, Regeneron, Viatris + Oyster Point

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.